Expert Talks - RB&HH Education

04 Sep 2023

This talk by Professor Polkey titles “Spleep: Worth Getting out of Bed for?” covers the topic of sleeps in patients with sleep apnea and how treatment can improve this disorder.

Professor Michael Polkey Background

Professor Michael Polkey is an academic and continues as a professor of respiratory medicine at Imperial College London.

Both Qatar and Kuwait invited him as a professor due to his expertise and knowledge in respiratory medicine and also acts in a clinical capacity in providing second opinions on patient diagnoses.

Moreover, professor Polkey specialises in many respiratory conditions, including: chronic obstructive pulmonary disease (COPD), respiratory aspects of neurological disease, advanced lung disease which results in respiratory failure, sleep disordered breathing, emphysema, diaphragm disease.

In particular, he is an expert in the management of chronic respiratory failure, treating COPD, weaning patients from invasive mechanical ventilation and he is an expert in neurological diseases as motor neurone disease (MND) known as amyotrophic lateral sclerosis (ALS) and Lou Gehrig’s disease.

The National Institute for Health Research (NIHR) funds the respiratory biomedical research unit at Royal Brompton Hospital and Professor Polkey is the deputy director. Prof Polkey acquired and directed many multi-faceted research projects, with many focused around COPD.

He has nearly 200 published scientific articles and sits as an associate editor for the European Respiratory Journal and Clinical Science. He is active on the board of Skeletal Muscle and the COPD journals and is well established in reviewing for all other major respiratory journals.

Professor Polkey supervises and examines PhD students at Imperial College London, and trains overseas students at Royal Brompton Hospital. He is also in demand on a global level as an international speaker.

Professor Michael Polkey Consultant respiratory physician

Curated For : General public / patient & Primary care doctors & Secondary care doctors
Subject : Respiratory medicine 45 Minutes

16 Aug 2023

Game Changing trials in Home Mechanical Ventilation: Standing on the Shoulder of Physiology Giants

This talk by Professor Nicholas Hart focuses on the “Game Changing trials in Home Mechanical Ventilation”.

Professor Nicholas Hart Background

He is professor of respiratory and critical care medicine, Faculty of Life Sciences and Medicine, School of Basic and Medical BioSciences, King’s College London. He is also director of research and development delivery, Guy’s and St Thomas’ NHS Foundation Trust. And joint editor-in-chief, Thorax.

Lane Fox Respiratory service, an internationally recognised weaning, rehabilitation and home mechanical ventilation service, appointed Nicholas as the director in April 2012. Since taking over, he has increased the activity by the introduction of seven-day working, opened the Lane Fox-REMEO Centre, re-structured the outpatient clinics, outpatient service and home ventilation service and increased the acuity of the inpatient service with installation of a comprehensive electronic patient record and central monitoring system. This has required an enhancement of the specialist workforce including consultants, junior doctors, nurses, allied health care professionals, technicians and administrative staff to support the service across paediatrics and adults.

Nicholas has developed a technology that has an intellectual property patent in the Europe (US pending) and this has resulted with close collaborative industry links with Philips. He has a master research agreement with Philips to develop and commercialise the Myotrace technology, which involved supervising a signal processing engineer working in the Lane Fox Clinical Respiratory Physiology Research Centre. Nicholas was appointed to the Philips Global Executive Pulmonary Advisory Board in 2014 with a primary role to identify and develop new technologies for respiratory health.

Nicholas’ research has received a total grant income of over £7 million with over £3.5 million in grants as lead applicant or primary supervisor since 2007.

Since 2009, he has successfully supervised seven students coming from the following universities: King’s College London PhD students, University College London, and Oxford University.

Professor Nicholas Hart

Curated For : Primary care doctors & Students
Subject : Respiratory medicine 50 Minutes

24 Jul 2023

Heart problems in cancer patients and the new ESC cardio-oncology guidelines

This talk by Dr Alexander Lyon on “heart problems in cancer patients and the new ESC cardio-oncology guidelines” sheds light on how modern cancer therapies cure cancer but might cause heart problems.

Dr Alexander Lyon Background

Dr Alexander Lyon, consultant cardiologist is the heart failure team lead and the cardiovascular biomedical research unit lead at Royal Brompton & Harefield Hospitals.

He studied at the University of Oxford, then trained as a junior doctor in cardiology in Oxford, London and also in Sydney, Australia. In 2005, he was awarded an MRC Clinical Research Training Fellowship and studied the influence of cardiac gene therapy on ventricular arrhythmia generation. In 2008 he completed his PhD and finished his cardiology training at St Mary’s Hospital and Royal Brompton Hospital.

Moreover, he has received several academic awards from the British Society for Cardiovascular Research, British Cardiovascular Society, Medical Research Society, International Society of Heart Research and the Royal Society of Medicine.

Dr Alexander Lyon is an expert in hypertension, heart valve disease, coronary artery disease, cardiomyopathy and specialises in heart failure, cardiac gene therapy, Takotsubo syndrome, cardiovascular diseases caused by cancer treatments, known as cardio-oncology, chemotherapy-induced heart failure and novel molecular and biological therapies for heart failure. He runs a specialist clinic focusing on risk prediction and management of refractory symptoms for patients with Takotsubo syndrome.

Dr Lyon also specialises in the investigation of cardiac symptoms like breathlessness, dizzy spells, chest pain, palpitations, and general cardiac health checks to guide risk factor management.

Dr Alexander Lyon is a senior lecturer at Imperial College London, where he supervises PhD students. He has presented at national and international meetings on regenerative medicine therapy in heart failure, chemotherapy-induced cardiac dysfunction and heart failure, cardiac calcium pathophysiology and Takotsubo cardiomyopathy

Dr Alexander Lyon Consultant cardiologist

Curated For : Allied Health Professional & Nurse & Primary care doctors & Secondary care doctors & Students & Tertiary care doctors
Subject : Cardiac surgery & Cardiology 50 Minutes

12 Jul 2023

Environmental hazards and cardiovascular disease

Prof. Thomas Muenzel covers the impacts and effects that Environmental Hazards have on Cardiovascular Disease.

Professor Thomas Muenzel Background

Professor Muenzel is currently the Chairmain of the Department of Cardiology at the University Medical Centre in Mainz, Germany.

Prof. Muenzel had published vastly in vascular biology and cardiology, alike; He made major contributions in the molecular mechanism and clinical effects of nitroglycerin and most recently, has focused his interest on environmental injuries on the cardiovascular system and its implications for cardiovascular health and disease; he has really pioneered this field that is currently centre stage worldwide. Based on his work he coined the term “exposome” as a new focus in cardiovascular prevention including environmental injuries.

He also held a faculty position at the University Hospital Eppendorf, Hamburg and has help his position since 2004.

Professor Thomas Munzel

Curated For : Primary care doctors & Students
Subject : Cardiac surgery & Cardiology 55 Minutes

30 Jun 2023

Sarcoidosis in primary care

SARCOIDOSIS IN PRIMARY CARE

This short talk on “Sarcoidosis in Primary Care” aims to assist general practitioners to consider sarcoidosis as a possible explanation for patients presenting with typical as well as non-specific symptoms and signs suggestive of this disease.

Early consideration of sarcoidosis as a possibility and referral to specialist sarcoidosis centres by GPs could prevent progression of symptoms and speed up the identification of extra pulmonary complications that can be life-threatening

DR. VASILIS KOURANOS BACKGROUND

Dr Vasilis Kouranos completed his training in respiratory medicine in 2013 at the General Hospital of Thoracic Diseases, the largest university hospital in Athens.

Dr Kouranos’ PhD at the University of Athens focused on screening CMR patients with biopsy-proven sarcoidosis. He was awarded a research scholarship grant for the study and his PhD was awarded in 2017 after his work was published in a high-impact journal which influences current practice in the field.

Dr Kouranos joined the Royal Brompton hospital as a clinical research fellow to Professor Athol Wells and in 2016 he was offered the role of senior clinical fellow and in parallel, acting consultant in the interstitial lung disease department.

He has great experience in management of patients with sarcoidosis, interstitial lung disease and pulmonary fibrosis.

Read More: here

Dr Vasilis Kouranos Consultant respiratory physician

Curated For : Primary care doctors & Students
Subject : Respiratory medicine 55 Minutes

15 May 2023

Ironman Trial

IRON MAN TRIAL OBJECTIVES

The Ironman trial examines the connection between patients with heart failure, reduced left ventricular ejection fraction, iron deficiency, intravenous ferric carboxymaltose administration and whether it improves quality of life and exercise capacity in the short term and reduces hospital admissions for heart failure up to one year. This study aimed to evaluate the longer-term effects of intravenous ferric derisomaltose on cardiovascular events in patients with heart failure.

PROFESSOR PAUL KALRA BACKGROUND

Todays RBH grand round is presented by Professor Paul Kalra. Professor Kalra started as a Consultant Cardiologist at Portsmouth Hospitals NHS Trust in April 2004. In 2019 he was appointed as Honorary Professor of Cardiology.

He is Chief Investigator for the BHF funded Ironman trial study evaluating the role of intravenous iron in patients with heart failure (IRONMAN – 75 UK centres), which has the potential to shape international guidelines and clinical practice.

Whilst he has a broad interest in all aspects of general adult cardiology, his sub-specialty interest is the assessment and management of patients with heart failure. He has championed local heart failure service development spanning primary, secondary and tertiary care. In addition, he co-developed the local complex device service, initiating local implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy device (CRT) implantation and follow up. Paul has extensive expertise in assessment of patients for and the implantation of pacemakers and other complex devices (CRT and ICD).

Paul has been on the British Society for Heart Failure Board since 2009 and was elected Chair 2017-2019 (now past chair). This is the national body providing expert advice, support and education to NHS organizations, professionals and patients (working closely with patient groups). During his role as Chair he was instrumental in getting heart failure recognised as a priority and incorporated into the NHS Long Term Plan published in 2019. He is currently helping to drive implementation of change, contributing to NHS England’s NHS Long Term Plan Heart Failure and Heart Valve Disease Expert Advisory Group. He has helped set up and is vice-chair of the committee for the British Heart Foundation (BHF) ‘hope for hearts’ innovation fund (up to £1 million to help support innovation to help deliver better heart failure care).

In 2019 the UK’s largest heart failure patient charity, Pumping Marvellous Foundation, presented Paul with the Platinum patient educator award – recognising extraordinary work towards building awareness of heart failure and advocacy of better systems to improve care for patients.

He is committed to medical education and has helped organise regular national meetings (see www.bsh.org.uk and www.cardiorenalforum.com) for hospital doctors, GPs and specialist nurses. He actively contributes to education of cardiology trainees through roles with national (British Cardiovascular Society) and international (European Society for Cardiology) societies. This has included question writing and exam setting for the European Exam in General Cardiology for 10 years and in 2020 was appointed Chair of the UK standard setting group for this exam.

He has over 100 peer review publications and has edited a textbook ‘Specialist Training in Cardiology’ which was Highly Commended in the BMA Medical Book Competition.

Professor Paul Kalra

Curated For : Secondary care doctors & Tertiary care doctors
Subject : Cardiology 58 Minutes

16 Feb 2023

The cool wall of bronchoscopy

Professor Pallav Shah covers bronchoscopy techniques and how these have evolved over time, providing insights into case studies.

Professor Pallav Shah

Curated For : Allied Health Professional & Secondary care doctors & Tertiary care doctors
Subject : Respiratory medicine 55 minutes

09 Feb 2023

The lung health crisis: The Achilles’ heel we didn’t know we had

This talk discusses lung disease and respiratory health related to pulmonary medicine, regarding the recent respiratory pandemic.

Professor MeiLan Han

Curated For : Allied Health Professional & Secondary care doctors & Tertiary care doctors
Subject : Respiratory medicine 1 hour

02 Feb 2023

Critically ill COVID-19 sub phenotypes and differential treatment effects

This talk provides insights into recent published work on the preliminary data on validation of critically ill COVID-19 patients.

Professor Manu Shankar-Hari

Curated For : Radiographers / technologists & Secondary care doctors & Tertiary care doctors
Subject : Respiratory medicine 1 hour

26 Jan 2023

Digital transformation: how digital tools will change healthcare

This talk focuses on multi-disciplinary discussions around opportunistic targeted AF case findings, utilising innovative ECG technology and how digital transformation is set to change healthcare.